Part D Protected Classes: Stakeholders Wary About “Expert Panel” Role
The roles of an outside contractor and expert panel in implementing Medicare Part D's policy on protected drug classes are sparking questions and concerns among stakeholders
You may also be interested in...
CMS is creating a multi-step process that will give outside experts and the public a role in adding or subtracting "protected" drug classes in Medicare Part D, as well as making exceptions to the rule that all drugs must be covered in a protected class
The new statutory requirement that Medicare drug plans cover all drugs in protected drug classes includes a hint of possible flexibility for interested stakeholders - the designated groups could be expanded or subtracted, though only through a formal regulatory process
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.